Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» rindopepimut
rindopepimut
Celldex Therapeutics To Enter Talks With FDA
Seeking Alpha
Tue, 11/18/14 - 10:35 am
Celldex Therapeutics
FDA
GBM
rindopepimut
glioblastoma multiforme
Celldex, ImmunoCellular Fall And Rise On Hype And Hope
Seeking Alpha
Wed, 11/27/13 - 08:31 am
ImmunoCellular Therapeutics
Celldex
rindopepimut
glioblastoma
ICT-107
Celldex: A View On The Imminent Release Of Data For The Cancer Vaccine Rindopepimut
Seeking Alpha
Mon, 11/4/13 - 03:16 pm
vaccines
glioblastoma
rindopepimut
Celldex
A Promising Platform for Cancer Immunotherapy
Motley Fool
Sat, 06/8/13 - 10:14 am
Celldex
rindopepimut
glioblastoma
2 Biotech Stocks To Consider This Week In The Wake Of Trial Data
Seeking Alpha
Thu, 12/13/12 - 11:33 am
Celldex
Alnylam
rindopepimut
ALN-TTR02
RNAi
Celldex Releases Data, Biostar Announces Q3 Results Date: Healthcare Business Review
Wall Street Cheat Street
Sat, 11/17/12 - 02:07 pm
Celldex
rindopepimut
glioblastoma
Biostar Pharmaceuticals
earnings
3 Things to Watch With Celldex Therapeutics
Motley Fool
Thu, 10/4/12 - 10:52 am
Celldex
rindopepimut
CDX-011
Pfizer
Bristol-Myers Squibb
Amgen
Seattle Genetics
Major FDA Approval Could Pave the Way for These 5 Biotechs
Seeking Alpha
Thu, 03/31/11 - 11:55 am
FDA
rindopepimut
brain cancer
Celldex
Geron
AML
GRNVAC1
blinatumomab
Micromet
non-Hodgkin's lymphoma
acute lymphoblastic leukemia
Oncothyreon
Stimuvax
breast cancer
lung cancer
Allovectin-7
Vical
melanoma